Trials / Completed
CompletedNCT04064437
Prevalence of Vertebral Fractures in Patients With Type 1 Diabetes
Prevalence of Vertebral Fractures in Patients With Type 1 Diabetes (Diabetes Spine Fractures, DenSiFy)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 192 (actual)
- Sponsor
- CHU de Quebec-Universite Laval · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
Background : Type 1 diabetes is associated with an increased risk of fractures. The mechanisms accounting for this bone fragility are not yet fully understood. The lower bone mineral density (BMD) observed in individuals with type 1 diabetes cannot solely explain the higher fracture incidence. Bone microarchitecture defects significantly contribute to bone fragility. Few studies assessed spine fractures in type 1 diabetes. This cross-sectional multicenter case-control study aims (1) to evaluate the prevalence of asymptomatic vertebral fractures in individuals with type 1 diabetes in comparison to age- and sex-matched healthy controls; (2) to compare individuals with diabetes with vertebral fractures and those without vertebral fracture using clinical, biochemical and radiological parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Clinical tests | The investigators perform the following clinical tests: vibration threshold test, monofilament test, and height, weight and waist circumference measurement in every participant. |
| DIAGNOSTIC_TEST | Clinical tests | The investigators perform the following clinical tests: height, weight and waist circumference measurement in every participant. |
| DIAGNOSTIC_TEST | Biochemical tests | The investigators perform blood and urine tests in every participant. |
| DIAGNOSTIC_TEST | DXA scan | The investigators perform a dual energy x-ray absorptiometry (DXA scan or osteodensitometry) in every participant. |
| DIAGNOSTIC_TEST | AGE Reader | The investigators perform a skin advanced glycation end products (AGEs) measurement with the AGE Reader machine in every participant. |
Timeline
- Start date
- 2019-07-29
- Primary completion
- 2021-03-02
- Completion
- 2021-03-02
- First posted
- 2019-08-21
- Last updated
- 2024-02-13
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT04064437. Inclusion in this directory is not an endorsement.